These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 38996712

  • 1. Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis.
    Mariottini A, Stack EH, Nair G, Nozzoli C, Wu T, Marchi L, Boncompagni R, Repice AM, Fainardi E, Pasquale FD, Carlesi E, Saccardi R, Jacobson S, Massacesi L.
    Mult Scler Relat Disord; 2024 Aug; 88():105745. PubMed ID: 38996712
    [Abstract] [Full Text] [Related]

  • 2. Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis.
    Mariottini A, Filippini S, Innocenti C, Forci B, Mechi C, Barilaro A, Fani A, Carlucci G, Saccardi R, Massacesi L, Repice AM.
    Mult Scler; 2021 Jan; 27(1):61-70. PubMed ID: 32008439
    [Abstract] [Full Text] [Related]

  • 3. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
    Casanova B, Jarque I, Gascón F, Hernández-Boluda JC, Pérez-Miralles F, de la Rubia J, Alcalá C, Sanz J, Mallada J, Cervelló A, Navarré A, Carcelén-Gadea M, Boscá I, Gil-Perotin S, Solano C, Sanz MA, Coret F.
    Neurol Sci; 2017 Jul; 38(7):1213-1221. PubMed ID: 28396953
    [Abstract] [Full Text] [Related]

  • 4. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
    Obradović D, Tukić L, Radovinović-Tasić S, Petrović B, Elez M, Ostojić G, Balint B.
    Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119
    [Abstract] [Full Text] [Related]

  • 5. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
    Rocca MA, Valsasina P, Meani A, Gobbi C, Zecca C, Barkhof F, Schoonheim MM, Strijbis EM, Vrenken H, Gallo A, Bisecco A, Ciccarelli O, Yiannakas M, Rovira A, Sastre-Garriga J, Palace J, Matthews L, Gass A, Eisele P, Lukas C, Bellenberg B, Margoni M, Preziosa P, Filippi M, MAGNIMS Study Group.
    J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
    [Abstract] [Full Text] [Related]

  • 6. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.
    Moore JJ, Massey JC, Ford CD, Khoo ML, Zaunders JJ, Hendrawan K, Barnett Y, Barnett MH, Kyle KA, Zivadinov R, Ma KC, Milliken ST, Sutton IJ, Ma DDF.
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):514-521. PubMed ID: 30538138
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis.
    Mariottini A, Bulgarini G, Forci B, Innocenti C, Mealli F, Mattei A, Ceccarelli C, Repice AM, Barilaro A, Mechi C, Saccardi R, Massacesi L.
    Eur J Neurol; 2022 Jun; 29(6):1708-1718. PubMed ID: 35146841
    [Abstract] [Full Text] [Related]

  • 11. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
    Rocca MA, Valsasina P, Meani A, Gobbi C, Zecca C, Rovira À, Montalban X, Kearney H, Ciccarelli O, Matthews L, Palace J, Gallo A, Bisecco A, Gass A, Eisele P, Lukas C, Bellenberg B, Barkhof F, Vrenken H, Preziosa P, Comi G, Filippi M, MAGNIMS Study Group.
    Neurology; 2019 Nov 12; 93(20):e1852-e1866. PubMed ID: 31611336
    [Abstract] [Full Text] [Related]

  • 12. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
    Lundell H, Svolgaard O, Dogonowski AM, Romme Christensen J, Selleberg F, Soelberg Sørensen P, Blinkenberg M, Siebner HR, Garde E.
    Acta Neurol Scand; 2017 Oct 12; 136(4):330-337. PubMed ID: 28070886
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preferential spinal cord volume loss in primary progressive multiple sclerosis.
    Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K.
    Mult Scler; 2019 Jun 12; 25(7):947-957. PubMed ID: 29781383
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
    Azodi S, Nair G, Enose-Akahata Y, Charlip E, Vellucci A, Cortese I, Dwyer J, Billioux BJ, Thomas C, Ohayon J, Reich DS, Jacobson S.
    Ann Neurol; 2017 Nov 12; 82(5):719-728. PubMed ID: 29024167
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation in highly active multiple sclerosis.
    Giedraitiene N, Kizlaitiene R, Peceliunas V, Griskevicius L, Kaubrys G.
    Sci Rep; 2020 Dec 04; 10(1):21286. PubMed ID: 33277590
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.
    Kalincik T, Sharmin S, Roos I, Massey J, Sutton I, Withers B, Freedman MS, Atkins H, Krasulova E, Kubala Havrdova E, Trneny M, Kozak T, Burman J, Macdonell R, Torkildsen Ø, Bø L, Lehmann AK, Sharrack B, Snowden J.
    J Neurol Neurosurg Psychiatry; 2024 Jul 15; 95(8):775-783. PubMed ID: 38538060
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.